FDA cites Truer Medical, Inc. in Orange following Feb. 13 inspection

Sean R. Keveney J.D., Chief Counsel of FDA
Sean R. Keveney J.D., Chief Counsel of FDA
0Comments

Truer Medical, Inc. in Orange received a single citation during a Feb. 13 inspection conducted by the Food and Drug Administration (FDA), according to data published on the FDA’s website.

The agency’s inspection focused on:

  • Compliance: Devices
  • Postmarket Assurance: Devices

FDA records indicate the company was cited for failing to maintain a design and development file for every medical device type or family of devices.

The FDA regularly inspects facilities nationwide to assess whether workplaces and products are in compliance with laws and regulations aimed at advancing public health. Results from these inspections are subsequently made publicly available.

The agency’s website describes the FDA as the government entity responsible for overseeing the safety and quality of human and animal medications, biological items, medical supplies, and tobacco products.

Information in this report comes from the U.S. Food and Drug Administration. Source data is available here.



Related

Mayor Ashleigh Aitken

Anaheim proposes stable 2026-27 budget with revenue growth and debt retirement plans

Anaheim has released its proposed budget for fiscal year 2026-27 with no service cuts planned amid rising revenues from tourism taxes and local economic activity. Officials anticipate retiring resort expansion debt next spring, which could lead to future surpluses.

Dr. Mehmet Oz CMS Administrator

Anaheim Medicaid spending on pathology, lab procedures jumps to $7.2 million in 2024

Medicaid payments for Pathology and Laboratory Procedures in Anaheim surged 59.4% in 2024, highlighting shifts in usage and reimbursement strategies.

Sean R. Keveney J.D., Chief Counsel of FDA

FDA cites FoodRGB, Inc. in Anaheim for 4 violations during May 13 inspection

The Food and Drug Administration (FDA) cited FoodRGB, Inc. in Anaheim for four violations related to foodborne biological hazards after a May 13 inspection, according to the FDA’s official website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from North OC Times.